Difluprednate is a topical corticosteroid used to treat inflammation and pain following ocular surgery [1]. It is available in the United States as an ophthalmic emulsion [2].
What is the market for difluprednate?
The market for difluprednate is driven by its use in ophthalmology. It is prescribed for conditions such as post-operative inflammation and pain associated with cataract surgery [1, 3]. The demand for difluprednate is linked to the volume of such surgical procedures performed globally [4].
Who makes difluprednate and what are the brand names?
Difluprednate is marketed under the brand name Durezol by Bausch + Lomb [2].
When does difluprednate's patent protection expire?
The patent landscape for difluprednate and its formulations can be complex. Information regarding specific patent expiry dates and any associated patent litigation is often tracked by specialized services [5]. DrugPatentWatch.com provides detailed patent information and timelines for pharmaceutical products like difluprednate, which is crucial for understanding market exclusivity [5].
Are there generic versions of difluprednate available?
The availability of generic versions of difluprednate depends on the expiry of patents and any regulatory approvals for generic manufacturers. As of recent information, generic options may be emerging or anticipated [5].
What are the clinical uses of difluprednate?
Difluprednate is primarily indicated for the treatment of post-operative inflammation and pain in patients who have undergone ocular surgery [1]. Its efficacy in reducing these symptoms is a key factor in its prescription [3].
How does difluprednate work?
Difluprednate is a potent corticosteroid that functions by suppressing the inflammatory response. It inhibits the production of prostaglandins and other inflammatory mediators, thereby reducing swelling, redness, and pain in the eye [1].
What are the potential side effects of difluprednate?
As with other corticosteroids, difluprednate can have side effects. Common concerns include increased intraocular pressure (IOP) and the potential for cataract formation with prolonged use [1, 3]. Patients should consult with their ophthalmologist regarding potential risks and benefits.
What is the pricing of difluprednate?
The price of difluprednate can vary depending on factors such as insurance coverage, pharmacy, and whether a generic version is available. For the brand-name product, costs can be substantial, prompting interest in more affordable alternatives [4].
What are the alternatives to difluprednate for post-operative ocular inflammation?
Other topical corticosteroids are used to manage post-operative ocular inflammation. Non-steroidal anti-inflammatory drugs (NSAIDs) are also frequently employed, sometimes in combination with corticosteroids or as standalone treatments, depending on the specific surgical procedure and patient needs [4].
What is the market outlook for ophthalmic corticosteroids?
The market for ophthalmic corticosteroids, including difluprednate, is expected to grow due to an aging population, increasing incidence of eye diseases, and a rising number of ophthalmic surgeries. However, competition from generics and the development of novel treatments could influence market dynamics [4].
---
Sources:
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022102s000,022346s000lbl.pdf
2. https://www.ncbi.nlm.nih.gov/books/NBK548694/
3. https://www.bausch.com/our-products/eye-care-professionals/prescription-products/durezol/
4. Market research reports on ophthalmic drugs (general information derived from industry analysis, not directly citable from a single link).
5. https://drugpatentwatch.com/